RxDoctor Payments DataLook up a doctor →

Joe Cummins, MD

Family Medicine · Conway, ARNPI 1063499150

Payments from drug & device makers

$15,405in general payments, 2019–2025

Across 1,198 payments — averaging $12.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • GSK$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$972
  • plus $7K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$1,842
Novo Nordisk108$1,579
GSK200$1,420
AstraZeneca48$1,360
Lilly USA, LLC106$1,184
Pfizer88$972
Abbott56$706
Otsuka America Pharmaceutical, Inc.37$659
Astellas Pharma US Inc29$543
Amgen(2 entities)30$461
Amarin Pharma, Inc.30$420
Boehringer Ingelheim20$313
Johnson & Johnson25$311
Bayer19$293
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$288
Esperion Therapeutics, Inc.16$234
Corium, LLC9$211
Merck19$188
Biohaven Pharmaceutical Holding Company Ltd.18$185
Teva Pharmaceuticals USA, Inc.13$166
Tris Pharma Inc8$154
Novartis17$148
Takeda Pharmaceuticals U.S.A., Inc.5$137
Biohaven Pharmaceuticals, Inc.14$135
Sanofi-aventis U.S. LLC7$96
Jazz Pharmaceuticals Inc.6$96
Shield Therapeutics Inc4$88
Antares Pharma, Inc.5$87
Corcept Therapeutics4$76
Kowa Pharmaceuticals America, Inc.6$75
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$71
Genentech USA, Inc.5$66
Alnylam Pharmaceuticals Inc.3$65
Sumitomo Pharma America, Inc.9$64
Exact Sciences4$61
Lundbeck LLC3$60
Sunovion Pharmaceuticals Inc.5$54
Boston Scientific2$54
Almatica Pharma LLC3$54
Ironshore Pharmaceuticals Inc.2$39
Eisai Inc.2$36
Dexcom, Inc.2$35
Collegium Pharmaceutical, Inc.2$33
Phathom Pharmaceuticals, Inc.3$31
Mylan Specialty L.p.2$30
Noven Therapeutics, LLC2$27
Shire North American Group Inc2$25
Avanir Pharmaceuticals, Inc.2$25
Currax Pharmaceuticals LLC2$23
E.r. Squibb & Sons, L.L.C.2$23
Arbor Pharmaceuticals, Inc.1$17
Bausch Health US, LLC1$17
Halozyme Inc1$17
Ironwood Pharmaceuticals, Inc1$14
Radius Health, Inc.1$13
Nevro Corp.1$12
Nestle Healthcare Nutrition Inc.1$12

How this compares

$15,405 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024
$14,031
Medicare patients
251
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Conway

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →